Skip to content
Tech Insights Hub

Giving Stem Cells in Utero to Babies with Spina Bifida Boosts Quality of Life, Trial Finds

An innovative medical trial has discovered that administering stem cells to unborn babies suffering from spina bifida as part of a surgical repair can be a "significant breakthrough" in managing prenatal disorders.

Study Parameters and Security

The research conducted in the United States involved six unborn babies with the 'open' form of spina bifida. Medical teams placed mother's placental stem cells on the exposed area of the baby's spinal cord during the repair procedure.

Significantly, the stem cell application demonstrated a favorable safety profile. The study team reported that the cells did not cause tumors, interfere with wound healing, or block the correction of co-occurring hindbrain herniation.

Positive Developments

Post-birth MRI scans indicated a successful correction of hindbrain herniation in each of the babies. This favorable anatomical change is a key indicator for enhanced physical outcomes.

"In the event it allows a greater number of infants able to walk who otherwise would not, it could establish itself as their standard of care," said the lead researcher. "These findings are extremely promising and create a pathway toward a variety of prospective new treatments."

Future Implications and Hope

Experts not involved in the trial proposed that additional validation of these apparent benefits could announce a "different age" in in-utero treatment. The potential to improve neural deficits seen in utero is considered a transformative goal.

Notably important would be improvements in bladder and bowel function, which are common challenges for people affected by this defect.

Future Directions

Despite this being a first-in-human effort was small in scale, its confirmed tolerability and hopeful trends create a solid basis for broader investigative efforts. The addition of cellular treatment with established fetal surgery techniques presents significant potential for changing life trajectories for infants diagnosed prenatally with this neural tube defect.

By

Tina Wiggins

A tech writer and digital strategist passionate about emerging technologies and their impact on society, with over a decade of industry experience.

Tech Insights Hub

Type to search articles.